faculty photo

Kiran Musunuru

Associate Professor of Medicine
Department: Medicine
Graduate Group Affiliations

Contact information
3400 Civic Center Blvd, Bldg 421
11-104 Smilow Center for Translational Research
Philadelphia, PA 19104
Office: 215-573-4717
AB (Biochemical Sciences)
Harvard College, Cambridge, MA, 1997.
PhD (Biomedical Sciences)
The Rockefeller University, New York, NY, 2003.
MD (Medicine)
Weill-Cornell Medical College, New York, NY, 2004.
MPH (Epidemiology)
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 2009.
Permanent link

Selected Publications

Musunuru Kiran, Lagor William R, Miano Joseph M: What Do We Really Think About Human Germline Genome Editing, and What Does It Mean for Medicine? Circulation: Cardiovascular genetics 10(5): e001910, Oct 2017.

Chadwick AC, Wang X, Musunuru K: In Vivo Base Editing of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) as a Therapeutic Alternative to Genome Editing. Arteriosclerosis, thrombosis, and vascular biology 37(9): 1741-1747, Sep 2017.

Chadwick AC; Musunuru K: CRISPR-Cas9 Genome Editing for Treatment of Atherogenic Dyslipidemia. Arteriosclerosis, thrombosis, and vascular biology Aug 2017.

Musunuru Kiran, Ingelsson Erik, Fornage Myriam, Liu Peter, Murphy Anne M, Newby L Kristin, Newton-Cheh Christopher, Perez Marco V, Voora Deepak, Woo Daniel: The Expressed Genome in Cardiovascular Diseases and Stroke: Refinement, Diagnosis, and Prediction: A Scientific Statement From the American Heart Association. Circulation: Cardiovascular genetics 10(4): e000037, Aug 2017.

Ormond Kelly E, Mortlock Douglas P, Scholes Derek T, Bombard Yvonne, Brody Lawrence C, Faucett W Andrew, Garrison Nanibaa' A, Hercher Laura, Isasi Rosario, Middleton Anna, Musunuru Kiran, Shriner Daniel, Virani Alice, Young Caroline E: Human Germline Genome Editing. American journal of human genetics 101(2): 167-176, Aug 2017.

Chadwick Alexandra C, Musunuru Kiran: Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing. Current atherosclerosis reports 19(7): 32, Jul 2017.

Musunuru Kiran, Kathiresan Sekar: Cardiovascular endocrinology: Is ANGPTL3 the next PCSK9? Nature reviews. Endocrinology Jul 2017.

Musunuru Kiran: The Hope and Hype of CRISPR-Cas9 Genome Editing: A Review. JAMA cardiology Jun 2017.

Pashos EE, Park Y, Wang X, Raghavan A, Yang W, Abbey D, Peters DT, Arbelaez J, Hernandez M, Kuperwasser N, Li W, Lian Z, Liu Y, Lv W, Lytle-Gabbin SL, Marchadier DH, Rogov P, Shi J, Slovik KJ, Stylianou IM, Wang L, Yan R, Zhang X, Kathiresan S, Duncan SA, Mikkelsen TS, Morrisey EE, Rader DJ, Brown CD, Musunuru K: Large, Diverse Population Cohorts of hiPSCs and Derived Hepatocyte-like Cells Reveal Functional Genetic Variation at Blood Lipid-Associated Loci. Cell stem cell 20(4): 558-570.e10, Apr 2017.

Warren CR; O'Sullivan JF; Friesen M; Becker CE; Zhang X; Liu P; Wakabayashi Y; Morningstar JE; Shi X; Choi J; Xia F; Peters D; Florido MHC; Tsankov AM; Duberow E; Comisar L; Shay J; Jiang X; Meissner A; Musunuru K; Kathiresan S; Daheron L; Zhu J; Gerszten RE; Deo RC; Vasan RS; O'Donnell CJ; Cowan CA: Induced Pluripotent Stem Cell Differentiation Enables Functional Validation of GWAS Variants in Metabolic Disease. Cell stem cell 20(4): 547-557.e7, Apr 2017.

back to top
Last updated: 10/20/2017
The Trustees of the University of Pennsylvania